Terms ending in 2034
Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,012,441 | Therapeutic Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,050,344 | Therapeutic Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,220,710 | Therapeutic Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,815,815 | Non-Selective Kinase Inhibitors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 10,246,438 | Non-Selective Kinase Inhibitors Pulmokine Inc.; Gilead Sciences, Inc. and Gilead Sciences, Inc. In force · High confidence | Pulmokine Inc.; Gilead Sciences, Inc. and Gilead Sciences, Inc. | In force | High confidence | |
| US 10,532,994 | Non-Selective Kinase Inhibitors In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,481,704 | 2'-Substituted Carba-Nucleoside Analogs for Antiviral Treatment In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,789,089 | Therapeutic Compounds In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,845,299 | Process for the Preparation of a Fluorolacton Derivative In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| US 9,624,183 | Process for the Preparation of a Fluorolacton Derivative In force · High confidence | Gilead Sciences, Inc. | In force | High confidence | |
| 52 more term ends in 2034 · Pro | |||||
10 of 62 patents shown. Soonest term end first, then patent number.
Pro members see all 62.
49 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.